Ambit Biosciences Secures $64,800,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ce8fb9cb-b82a-4fa0-8336-60969f1d2930&Preview=1
Date
5/16/2013
Company Name
Ambit Biosciences
Mailing Address
4215 Sorrento Valley Blvd. San Diego, CA 92121
Company Description
Ambit Biosciences (NASDAQ: AMBI) is a privately-held biopharmaceutical company engaged in the discovery and development of small-molecule kinase inhibitors for the treatment of cancer.
Website
http://www.ambitbio.com
Transaction Type
IPO
Transaction Amount
$64,800,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC.
M&A Terms